Waters Corp
NYSE:WAT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
277.72
417.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
WAT
stock under the Base Case scenario is
312.44
USD.
Compared to the current market price of 396.75 USD,
Waters Corp
is
Overvalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Waters Corp.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
The rapid consolidation of key pharmaceutical clients, combined with pressured R&D budgets, could curtail demand for Waters’ premium chromatography and mass spectrometry instruments, putting a cap on near-term revenue growth.
Strong competition from larger players such as Thermo Fisher Scientific and Agilent, which can bundle products and services more effectively, risks eroding Waters’ market share in critical segments like biopharma and food safety testing.
Waters’ heavy reliance on a specialized product lineup leaves it vulnerable to niche market downturns or technological disruption, potentially limiting its ability to adapt quickly to shifting research priorities in life sciences.
Waters’ leadership in high-end liquid chromatography and mass spectrometry makes its instruments indispensable for cutting-edge pharmaceutical and biopharmaceutical research, positioning it to capture growth from increasing biologics development pipelines.
Ongoing investments in new product launches, such as advanced mass spectrometry tools and informatics solutions, should expand Waters’ addressable market and deepen relationships with both academic and industrial clients.
Waters maintains a robust service model and strong customer loyalty, reflected in recurring revenues from consumables and software, which help stabilize its cash flows and reinforce its premium brand reputation.
Revenue & Expenses Breakdown
Waters Corp
Balance Sheet Decomposition
Waters Corp
| Current Assets | 1.9B |
| Cash & Short-Term Investments | 459.1m |
| Receivables | 748.5m |
| Other Current Assets | 711.6m |
| Non-Current Assets | 2.9B |
| PP&E | 713.4m |
| Intangibles | 1.9B |
| Other Non-Current Assets | 320.9m |
| Current Liabilities | 1.3B |
| Accounts Payable | 115.7m |
| Accrued Liabilities | 120.4m |
| Other Current Liabilities | 1B |
| Non-Current Liabilities | 1.3B |
| Long-Term Debt | 947.2m |
| Other Non-Current Liabilities | 333.4m |
Free Cash Flow Analysis
Waters Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Waters Corp
|
Revenue
|
3.1B
USD
|
|
Cost of Revenue
|
-1.3B
USD
|
|
Gross Profit
|
1.8B
USD
|
|
Operating Expenses
|
-1B
USD
|
|
Operating Income
|
824.3m
USD
|
|
Other Expenses
|
-175.5m
USD
|
|
Net Income
|
648.8m
USD
|
WAT Profitability Score
Profitability Due Diligence
Waters Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Waters Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
WAT Solvency Score
Solvency Due Diligence
Waters Corp's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Waters Corp's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WAT Price Targets Summary
Waters Corp
According to Wall Street analysts, the average 1-year price target for
WAT
is 416.74 USD
with a low forecast of 354.94 USD and a high forecast of 504 USD.
Dividends
Current shareholder yield for
WAT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WAT
stock under the Base Case scenario is
312.44
USD.
Compared to the current market price of 396.75 USD,
Waters Corp
is
Overvalued by 21%.